Positive No-Template Control in a Quantitative CMV Assay
It is Tuesday morning in a laboratory that quantitates CMV DNA in plasma by real-time PCR, reported in IU/mL after WHO-standardization. Monday's run contained 16 patient samples, one no-template control (NTC), and a 500 IU/mL low positive control. The NTC amplified at Ct 37.8; the low positive gave 480 IU/mL. The NTC was negative in the three previous runs, and the current primer/probe and master mix lot has been in use for three weeks. Two transplant recipients in this run reported 170 and 260 IU/mL after six negative weeks; both are asymptomatic. A technologist recalls that last Wednesday an amplified 96-well plate was opened on the bench next to the extraction area because the plate reader was occupied, and one well containing 1.2 x 10^6 IU/mL splashed.
1. What is the most likely source of the positive NTC, and what is the evidence for and against a reagent-contamination explanation?
Read the worked answer
Most likely: low-level amplicon carryover from the opened, splashed high-positive plate onto surfaces, racks, or gloves adjacent to the extraction bench, subsequently transferred into the NTC well.
Evidence for amplicon carryover:
- The NTC signal is late (Ct 37.8), consistent with a very small number of intact amplicon copies, not with a concentrated reagent contaminant.
- There is a plausible breach event (open plate outside the post-amplification area, visible splash) close in time.
- Prior runs were clean, arguing against a long-standing reagent problem.
Evidence against / must be excluded:
- A reagent or master mix contaminant would typically reproduce across plates and across multiple wells in a run, and would not correlate with a one-time bench event.
- Only one NTC was tested, so the within-run pattern is uninformative. Test 8 NTC wells using a fresh, unopened reagent aliquot and fresh tips. Reproducible positivity across those wells points to reagents; sporadic, position-associated positivity points to surface or operator contamination.
- Splash contamination can also enter through shared racks, pipettes, or the centrifuge - swab these.
2. What happens to the patient results from Monday's run, and specifically to the 170 and 260 IU/mL results?
Read the worked answer
The run is invalid and no patient result from it may be reported. A positive NTC violates the run acceptance criteria; the magnitude of the patient values is irrelevant to that rule.
The two low positives must be held, not released. They are exactly the results most vulnerable to a low-level contamination event: low viral loads, asymptomatic patients, and a break from six weeks of negativity. Holding them prevents a false-positive result from triggering preemptive therapy or a reduction in immunosuppression.
Actions:
- Do not report; notify the medical director and the clinical teams that results are pending.
- Re-extract the two patients from stored plasma collected before the contamination event - re-amplifying the old extract will not distinguish contamination from true viremia.
- Re-run the entire batch only after decontamination is verified.
- If the repeat is negative, the original result is discarded; if reproducibly positive at the same low level with a clean NTC, report with a comment and interpret in the context of the trend rather than a single value.
3. Outline the decontamination and verification sequence, and one procedural change to prevent recurrence.
Read the worked answer
Sequence (surfaces before equipment, top to bottom):
- Discard opened master mix, primer/probe aliquots, plate sealers, and any tube or rack present on the affected bench; use only unopened lots.
- Wipe surfaces, pipettes, racks, and the centrifuge with 10% freshly prepared hypochlorite (amplicon DNA must be destroyed chemically), allow contact time, then wipe with water or 70% ethanol to remove bleach residue, which itself inhibits PCR.
- Clean the plate reader and its surroundings; the splash occurred there.
- UV the surface area overnight as an adjunct - UV is surface-only and does not penetrate tubes or dried material.
- Decontaminate the extraction area separately, in the opposite direction of workflow (amplification to extraction), and change gloves and lab coats between zones.
Verification: 8 NTC wells across positions with fresh reagents, plus environmental swabs of the reader bench and extraction bench; swabs should be negative before patient testing resumes.
Procedural change: enforce unidirectional workflow - amplified plates are never opened in or carried through the extraction/pre-PCR area; a second plate reader or a scheduled reader time must be available so the rule is never in conflict with capacity.